ZEG Berlin

Zentrum für Epidemiologie und Gesundheitsforschung

Christian Franke

Director, Data Management

Christian Franke oversees the team designing and administrating ZEG Berlin’s database management system. He ensures the systems are flexible in response to emerging technological developments and changes in the industry.

Christian received his bachelor in life science from the University of Applied Sciences and Arts, Hannover and was awarded a Master of Science (Epidemiology) from Berlin School of Public Health. He has been a member of ZEG Berlin since 2005.

 

Publications

Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Hagemann Christine, Moehner Sabine, Unintended pregnancies in users of different combined oral contraceptives - final results from the INAS-SCORE study. Pharmacoepidemiology and Drug Safety. 2015; 24 (S1): 1–587. 10.1002/pds.3838.
Dinger Jürgen, Bardenheuer Kristina, Franke Christian, The risk of VTE in users of a 24-day regimen of a combined oral contraceptive compared to conventional 21-day OC regimes: results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 131.
Dinger Jürgen, Franke Christian, Use of hormonal contraceptives in europe and in the USA: comparative data from the TASC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 182.
Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Impact of obesity on the safety and effectiveness of oral contraceptives. 56. GMDS-Jahrestagung und 6. DGEpi-Jahrestagung, German Medical Science GMS Publishing House. 2011; Doc11gmds331..
Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Sicherheit und effektivität von oralen kontrazeptiva bei jugendlichen. Gesundheitswesen. 2010; 72:624.
Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Franke Christian, Leddin Janko, Differences in drug utilization of oral contraceptives in the US and Europe. Pharmacoepidemiology and Drug Safety. 2010; 19:S241.
Bardenheuer Kristina, Barnett Clare, Dinger Jürgen, Franke Christian, Risk profile and OC utilization patterns of women enrolled in INAS-SCORE. Pharmacoepidemiology and Drug Safety. 2010; 19:S30.